Statements (28)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
|
| gptkbp:ATCCode |
none (not assigned)
|
| gptkbp:CASNumber |
gptkb:557795-19-4
|
| gptkbp:clinicalTrialPhase |
Phase II
|
| gptkbp:developer |
gptkb:Merck
|
| gptkbp:drugClass |
gptkb:recombinant_human_growth_hormone
ghrelin receptor agonist |
| gptkbp:hasChemicalStructure |
C27H36N4O5S
|
| gptkbp:hasInChIKey |
QZJTYWZEBPJYTH-UHFFFAOYSA-N
|
| gptkbp:hasMolecularFormula |
C27H36N4O5S
|
| gptkbp:hasSMILES |
CC(C)CN(C)CCCN=C(N)NCC1=CC=CC=C1C(=O)NC2=CC=CC=C2S(=O)(=O)C
|
| gptkbp:hasTherapeuticUse |
treatment of growth hormone deficiency
treatment of osteoporosis treatment of obesity treatment of muscle wasting |
| gptkbp:hasUNII |
QX8X9N6F2H
|
| gptkbp:isNotApprovedBy |
gptkb:FDA
gptkb:EMA |
| gptkbp:legalStatus |
investigational
|
| gptkbp:molecularWeight |
528.66 g/mol
|
| gptkbp:name |
gptkb:MK-677
|
| gptkbp:PubChem_CID |
159633
CHEMBL1231375 |
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:synonym |
gptkb:Ibutamoren
|
| gptkbp:bfsParent |
gptkb:sunitinib
|
| gptkbp:bfsLayer |
7
|
| https://www.w3.org/2000/01/rdf-schema#label |
557795-19-4
|